<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1102646</article-id><article-id pub-id-type="publisher-id">OALibJ-69302</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  Structure of Aldoses Condensation Products with &lt;em&gt;SH&lt;/em&gt;-Containing Hydrazides
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Andrei</surname><given-names>Yu Ershov</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Igor</surname><given-names>V. Lagoda</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Stanislav</surname><given-names>I. Yakimovich</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lyudmila</surname><given-names>Yu Kuleshova</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marina</surname><given-names>Yu Vasileva</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Irina</surname><given-names>S. Korovina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Valery</surname><given-names>V. Shamanin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Scientific Research Test Center (Medical and Biological Protection), Institute of Military Medicine, Saint Petersburg, Russia</addr-line></aff><aff id="aff4"><addr-line>I.P. Pavlov Ryazan State Medical University, Ryazan, Russia</addr-line></aff><aff id="aff1"><addr-line>Institute of Macromolecular Compounds, Russian Academy of Sciences, Saint Petersburg, Russia</addr-line></aff><aff id="aff3"><addr-line>Saint Petersburg State University, Saint Petersburg, Russia</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>ershov305@mail.ru(AYE)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>05</month><year>2016</year></pub-date><volume>03</volume><issue>05</issue><fpage>1</fpage><lpage>6</lpage><history><date date-type="received"><day>12</day>	<month>April</month>	<year>2016</year></date><date date-type="rev-recd"><day>accepted</day>	<month>14</month>	<year>May</year>	</date><date date-type="accepted"><day>23</day>	<month>May</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   The structure of the condensation products of thiobenzohydrazide, 2-sulfanylacetohydrazide, 3-sulfanylpropiohydrazide, and 2-sulfanylbenzohydrazide with a series of aldoses (L-arabinose, D-ribose, L-rhamnose, D-galactose, D-glucose, and D-mannose) was studied by 
   <sup style="line-height:1.5;">1</sup>
   H- and 
   <sup style="line-height:1.5;">13</sup>
   C-NMR spectroscopy. 
  
 
</p></abstract><kwd-group><kwd>Aldoses &lt;i&gt;SH&lt;/i&gt;-Acylhydrazones</kwd><kwd> 1</kwd><kwd>3</kwd><kwd>4-Thiadiazolines</kwd><kwd> 1</kwd><kwd>3</kwd><kwd>4-Thiadiazines</kwd><kwd> 1</kwd><kwd>3</kwd><kwd>4-Thiadiazepines</kwd><kwd> Ring-Chain-Ring Tautomerism</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Condensation products of aldoses with acylhydrazines attracted attention due to their high biological activity. Some of them exhibited an antimicrobial [<xref ref-type="bibr" rid="scirp.69302-ref1">1</xref>] and antifungal [<xref ref-type="bibr" rid="scirp.69302-ref2">2</xref>] activity. Among aldoses acylhydrazones, containing in their structure, a functional sulfohydryl group is known only thiobenzohydrazones of arabinose, glucose and mannose [<xref ref-type="bibr" rid="scirp.69302-ref3">3</xref>] , as well as 2-sulfonylbenzohydrazones of arabinose and glucose [<xref ref-type="bibr" rid="scirp.69302-ref4">4</xref>] , the structure of which is not proved. The presence of a functional nucleophilic SH-group in the aldosohydrazone fragment could give rise in appearance of new structural possibilities in further transformations. Intermolecular nucleophilic attacks of SH-fragments at the C=N polar bond contained in the linear structure can lead to repeated cyclization with the formation of new cyclic forms.</p><p>The aim of the present work was to study of the structure of the condensation products of aldoses with hydrazides of thiobenzoic (PhCSNHNH<sub>2</sub>), sulfanylacetic (HSCH<sub>2</sub>CONHNH<sub>2</sub>), 3-sulfanylpropionic (HSCH<sub>2</sub>CH<sub>2</sub>CONHNH<sub>2</sub>), and 2-sulfanylbenzoic (2-HSC<sub>6</sub>H<sub>4</sub>CONHNH<sub>2</sub>) acids by <sup>1</sup>H- and <sup>13</sup>C-NMR spectroscopy methods (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec><sec id="s2"><title>2. Results and Discussion</title><p>Compounds 1-4 were synthesized in yields 55% - 90% by heating equimolar amounts of the corresponding aldose (L-arabinose, D-xylose, D-ribose, L-rhamnose, D-galactose, D-glucose, D-mannose) and corresponding sulfur-containig hydrazide (thiobenzohydrazide, 2-sulfanylacetohydrazide, 3-sulfanylpropiohydrazide, 2-sulfa- nylbenzohydrazide) in boiling methanol for a short time (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="table" rid="table3">Table 3</xref>, and <xref ref-type="table" rid="table4">Table 4</xref>).</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Aldoses thiobenzoylhydrazones 1a-1e</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/69302x7.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Aldoses 2-sulfanylacetylhydrazones 2a-2f</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/69302x8.png"/></fig><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Aldoses 3-sulfanypropionyhydrazones 3a-3f</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/69302x9.png"/></fig><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Aldoses 2-sulfanylbenzoylhydrazones 4a-4f</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/69302x10.png"/></fig><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Tautomeric composition of aldoses thiobenzoylhydrazones 1a-1e (72 h after dissolution)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Compound</th><th align="center" valign="middle"  rowspan="2"  >R</th><th align="center" valign="middle"  rowspan="2"  >Initial aldose</th><th align="center" valign="middle"  rowspan="2"  >Form in crystals</th><th align="center" valign="middle"  colspan="3"  >Tautomeric composition (%) in DMSOd<sub>6</sub></th></tr></thead><tr><td align="center" valign="middle" >Form B</td><td align="center" valign="middle" >Form A</td><td align="center" valign="middle" >Form C</td></tr><tr><td align="center" valign="middle" >1a</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >L-Arabinose</td><td align="center" valign="middle" >C</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >60</td></tr><tr><td align="center" valign="middle" >1b</td><td align="center" valign="middle" >CH<sub>3</sub></td><td align="center" valign="middle" >L-Rhamnose</td><td align="center" valign="middle" >C</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >70</td></tr><tr><td align="center" valign="middle" >1c</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Galactose</td><td align="center" valign="middle" >C</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >65</td></tr><tr><td align="center" valign="middle" >1d</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Glucose</td><td align="center" valign="middle" >C</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >45</td></tr><tr><td align="center" valign="middle" >1e</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Mannose</td><td align="center" valign="middle" >C</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >80</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Tautomeric composition of aldoses 2-sulfanylacetylhydrazones 2a-2f (72 h after dissolution)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Compound</th><th align="center" valign="middle"  rowspan="2"  >R</th><th align="center" valign="middle"  rowspan="2"  >Initial aldose</th><th align="center" valign="middle"  rowspan="2"  >Form in crystals</th><th align="center" valign="middle"  colspan="3"  >Tautomeric composition (%) in D<sub>2</sub>O</th></tr></thead><tr><td align="center" valign="middle" >Form B</td><td align="center" valign="middle" >Form A</td><td align="center" valign="middle" >Form C</td></tr><tr><td align="center" valign="middle" >2a</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >L-Arabinose</td><td align="center" valign="middle" >D</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >90</td></tr><tr><td align="center" valign="middle" >2b</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >D-Xylose</td><td align="center" valign="middle" >D</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >75</td></tr><tr><td align="center" valign="middle" >2c</td><td align="center" valign="middle" >CH<sub>3</sub></td><td align="center" valign="middle" >L-Rhamnose</td><td align="center" valign="middle" >B</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >2d</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Galactose</td><td align="center" valign="middle" >D</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >85</td></tr><tr><td align="center" valign="middle" >2e</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Glucose</td><td align="center" valign="middle" >B</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >2f</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Mannose</td><td align="center" valign="middle" >D</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >90</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Tautomeric composition of aldoses 3-sulfanypropionyhydrazones 3a-3f (72 h after dissolution)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Compound</th><th align="center" valign="middle"  rowspan="2"  >R</th><th align="center" valign="middle"  rowspan="2"  >Initial aldose</th><th align="center" valign="middle"  rowspan="2"  >Form in crystals</th><th align="center" valign="middle"  colspan="3"  >Tautomeric composition (%) in D<sub>2</sub>O</th></tr></thead><tr><td align="center" valign="middle" >Form B</td><td align="center" valign="middle" >Form A</td><td align="center" valign="middle" >Form C</td></tr><tr><td align="center" valign="middle" >3a</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >L-Arabinose</td><td align="center" valign="middle" >E</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >3b</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >D-Xylose</td><td align="center" valign="middle" >E</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >40</td></tr><tr><td align="center" valign="middle" >3c</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >D-Ribose</td><td align="center" valign="middle" >E</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >3d</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Galactose</td><td align="center" valign="middle" >B</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >3e</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Glucose</td><td align="center" valign="middle" >B</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >3f</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Mannose</td><td align="center" valign="middle" >B</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >20</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Tautomeric composition of aldoses 2-sulfanylbenzoylhydrazones 4a-4f (72 h after dissolution)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Compound</th><th align="center" valign="middle"  rowspan="2"  >R</th><th align="center" valign="middle"  rowspan="2"  >Initial aldose</th><th align="center" valign="middle"  rowspan="2"  >Form in crystals</th><th align="center" valign="middle"  colspan="3"  >Tautomeric composition (%) in DMSOd<sub>6</sub></th></tr></thead><tr><td align="center" valign="middle" >Form B</td><td align="center" valign="middle" >Form A</td><td align="center" valign="middle" >Form C</td></tr><tr><td align="center" valign="middle" >4a</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >L-Arabinose</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >4b</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >D-Ribose</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >4c</td><td align="center" valign="middle" >CH<sub>3</sub></td><td align="center" valign="middle" >L-Rhamnose</td><td align="center" valign="middle" >F, B</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >45</td></tr><tr><td align="center" valign="middle" >4d</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Galactose</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >4e</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Glucose</td><td align="center" valign="middle" >F, B</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >55</td></tr><tr><td align="center" valign="middle" >4f</td><td align="center" valign="middle" >CH<sub>2</sub>OH</td><td align="center" valign="middle" >D-Mannose</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >50</td></tr></tbody></table></table-wrap><p>In all experiments, the <sup>1</sup>H- and <sup>13</sup>C-NMR spectra were recorded at definite time intervals starting from the moment of dissolution until the end of transformations. In addition, the structure of the compounds under study in the crystalline state was confirmed by solid-phase high-resolution <sup>13</sup>C-NMR spectroscopy (CPMAS). For example, pyranose form B was expected to give a signal from the anomeric C-1 atom at δ 85 - 90 ppm; analogous signals from five-membered 1,3,4-thiadiazoline C form, six-membered 1,3,4-thiadiazine D form, or seven- membered 1,3,4-thiadiazepine E and F forms should appear in a stronger field, at δ 70 - 75 ppm. It is typical of sp<sup>3</sup>-hybridized carbon atom for saturated ring systems, located between sulfur and nitrogen atoms [<xref ref-type="bibr" rid="scirp.69302-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.69302-ref6">6</xref>] . Hydrazone structure A should give rise to a downfield signal at δ 145 - 155 ppm (C=N) in the <sup>13</sup>C-NMR spectrum.</p><p>One set of signals belonging to 1,3,4-thiadiazoline form C is observed in <sup>1</sup>H- and <sup>13</sup>C-NMR spectra of the products of the condensation of aldoses with thiobenzohydrazide 1a-1e (<xref ref-type="table" rid="table1">Table 1</xref>). This finding suggests that compounds 1a-1e has the same structure in the crystalline state. Solid-phase <sup>13</sup>C-NMR spectrum was recorded for arabinose condensation product 1a. When the spectral patterns of solutions of compounds 1a-1e to in DMSOd<sub>6</sub> no longer changed indicating the achievement of an equilibrium state (72 h after the dissolution), signals corresponding to linear hydrazone structure A were fixed. In the case of glucose tiobenzoylhydrazone 1d about 10% of the pyranose form B can be detected.</p><p>In the <sup>1</sup>H- and <sup>13</sup>C-NMR spectra of solutions of aldoses sulfanylacetylhydrazones 2a, 2b, 2d, and 2f in D<sub>2</sub>O (other solvents proved to be unsuitable due to the low solubility) the observed signals corresponded to cyclic tautomeric forms B and D, and mainly each of these forms was present as two stereoisomers: α,β-B and (2R,S)-D or (D and D′) (<xref ref-type="table" rid="table2">Table 2</xref>). The relative intensity of signals belonging to forms B and D in the <sup>13</sup>C-NMR spectra changed with time; after 72 h these variations finished indicating the attainment of the equilibrium state. Therewith in the <sup>13</sup>C NMR spectra of compounds 2a, 2b, 2d, and 2f taken just after the dissolution the intensity of signals belonging to the thiadiazine form D was significantly higher than in the spectra registered after the establishment of the equilibrium. This fact suggests that in the crystalline state compounds 2a, 2b, 2d, and 2f exist in the thiadiazine structure D, and in solution they are partially converted in the pyranose form B. On the contrary, at recording of the <sup>13</sup>C-NMR spectra of the glucose derivative 2e the intensity of signals of pyranose form B decreased with time and the intensity of the signals of thiadiazine form D grew, suggesting that in the crystalline state this compound had the pyranose structure A. Finally, in the <sup>13</sup>C-NMR spectra of rhamnose derivative 2c both just after dissolution and 72 h later only the signals of pyranose form B were observed. In neither example we could detect the hydrazone form A; consequently the name “sulfanylacetylhydrazone” could be applied to these systems only tentatively.</p><p>Compounds 3a-3f were expected to exhibit complicated tautomeric behavior due to their ability to undergo cyclization with formation of both six-membered pyranose form B and seven-membered 1,3,4-thiadiazepin form E (<xref ref-type="table" rid="table3">Table 3</xref>). According to <sup>13</sup>C-NMR spectra taken off in solid phase, the condensation products of 3-sulfanyl&#173;propionylhydrazine with arabinose, xylose, and ribose (compounds 3a-3c respectively) exist in crystalline state as thiadiazepins E. Two sets of the signals belonging to the configurational isomers of thiadiazepin forms E and E′ appeared in the solid phase <sup>13</sup>C-NMR spectrum of compound 3a. It was impossible to determine the 2R- or 2S-configuration of these forms. Unlike pentose derivatives 3a-3c, the condensation products 3d-f derived from 3-sulfanylpropionylhydrazine and hexoses do not give rise to cyclic thiadiazepin form E in crystals. Compounds 3d-3f in the crystalline state has cyclic structure B. The <sup>1</sup>H-NMR spectra of solutions of 3-sulfanylpropanoyl&#173;hydrazones 3a-3f in D<sub>2</sub>O, recorded immediately after dissolution, contained signals assignable to pyranose structure B. After 72 h, i.e., when the spectral patterns of solutions of 3a-3f in D<sub>2</sub>O no longer changed (equilibrium was attained), signals corresponding to both cyclic tautomers B and E and linear hydrazone structure A were present, and each cyclic tautomer was a mixture of two stereoisomers: α,β-B and (2R,S)-E or (E and E′). The equilibrium position varies over a wide range: from В:А:E ratio 85:5:10 for glucose derivative 3e to 50:10:40 for xylose derivative 3b respectively.</p><p>A different situation was observed with the condensation products obtained from aldoses and 2-sulfanylben- zohydrazide (<xref ref-type="table" rid="table4">Table 4</xref>). Judging by variation of their <sup>1</sup>H- and <sup>13</sup>C-NMR spectra, compounds 4a- 4f in the crystalline state have cyclic 1,3,4-benzothiadiazepin structure F. Solid-phase <sup>13</sup>C-NMR spectrum was recorded for glucose condensation product 4e. With the lapse of time, signals belonging to the second configurational isomer of benzothiadiazepin form F′ appeared in the <sup>1</sup>H- and <sup>13</sup>C-NMR spectra of solutions of 4a-4f in DMSOd<sub>6</sub>, but it was impossible to assign these signals to particular (2R)- or (2S)-isomer. The <sup>1</sup>H- and <sup>13</sup>C-NMR spectra of condensation products 4a, 4b, and 4d derived from arabinose, ribose, and galactose no longer change in 15 - 20 days, indicating the absence of linear structure A and cyclic form B in the equilibrium mixture. Compounds 4c and 4e obtained by condensation of 2-sulfanylbenzohydrazide with rhamnose and glucose behaved differently. After keeping their solutions in DMSOd<sub>6</sub> for 72 h, the <sup>1</sup>H- and <sup>13</sup>C-NMR data indicated formation of cyclic pyranose form B (two sets of signals were observed due to the presence of several stereoisomers). Up to 20% of linear hydrazone tautomer A was detected for rhamnose derivative 4c. After 30 days, the <sup>1</sup>H- and <sup>13</sup>C-NMR spectra of compounds 4c and 4e contained only signals belonging to pyranose form B. We succeeded in isolating tautomer B of compound 4c in the crystalline state, and its structure was confirmed by the solid-phase <sup>13</sup>C-NMR spectrum. In other words, compounds 4c and 4e demonstrated irreversible transformation of benzo-1,3,4-thiadiazepin tautomer F into tetrahydropyran structure B, which can be observed spectrally. The <sup>1</sup>H- and <sup>13</sup>C-NMR spectra of the condensation product of 2-sulfanylbenzohydrazide with mannose (compound 4f ) finished to change in 72 h. The equilibrium mixture consisted of 50% of benzothiadiazepin tautomer F, 15% of linear structure A, and 35% of pyranose B form; in addition, each cyclic tautomer was a mixture of two stereoisomers.</p></sec><sec id="s3"><title>3. Conclusion</title><p>Thus, the study noted the general tendency of the condensation products of aldoses with thiobenzoic, sulfanylacetic, 3-sulfanylpropionic, and 2-sulfanylbenzoic acids hydrazides to undergo ring-chain-ring tautomeric transformation involving two different cyclic structures via intramolecular nucleophilic addition of the SH group at the hydrazone C=N bond. The results of the present study may be interesting from the practical viewpoint, e.g., for the design of new radioprotective agents as well as of polymeric materials for techniques, medicine, and biology. The condensation products of SH-acylhydrazides with aldoses may also be applied for complexing the colloid species of the noble metals controlling their structure and the size of the forming nanoparticles and thus governing the process of their self-organization into supramolecular structures [<xref ref-type="bibr" rid="scirp.69302-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.69302-ref8">8</xref>] . This will be the subject of our future investigations.</p></sec><sec id="s4"><title>4. Experimental Part</title><p><sup>1</sup>Н- and <sup>13</sup>С-NMR spectra were registered on a spectrometer Bruker AV-400 at operating frequencies 400 and 100 MHz respectively (internal reference hexamethyldisiloxane). The solid-phase <sup>13</sup>C-NMR spectra were obtained on a Bruker AM-500 spectrometer (125 MHz) using a standard procedure utilizing cross polarization and magic angle spinning (CPMAS) technique (frequency 4.5 kHz; internal reference hexamethylbenzene). The tautomeric composition of obtained compounds was estimated by the integration of the appropriate signals in the <sup>1</sup>Н NMR spectra. Elemental analysis of previously unknown compounds was carried out on a CHN Analyzer Hewlett Packard 185B. The purity of prepared compounds was checked by TLC on Silufol UV-254 plates, eluent butanol-water-acetone, 8:1:1.</p><p>Synthesis of aldoses SH-acylhydrazones (1-4)</p><p>To a solution of 0.01 mol of SH-containing hydrazide in 25 ml of methanol 0.01 mol of an appropriate aldose was added, and the mixture was boiled for a period of 1-3 h. The solvent was removed at a reduced pressure, and the residue was washed with ether (3 &#215; 50 ml), and the colorless crystalline substance was filtered off on a glass filter funnel (40 - 100 μm), dried and stored in a desiccator over P<sub>2</sub>O<sub>5</sub>.</p><p>L-Arabinose thiobenzoylhydrazone (1a)</p><p>Yield 70%, m.p. 161˚C - 162˚C (lit. [<xref ref-type="bibr" rid="scirp.69302-ref3">3</xref>] m.p. 163˚C - 164˚C). <sup>13</sup>C-NMR spectrum (solid phase): δ = form C(100%): 64.23 (C-5), 70.21 (C-2), 71.15 (C-3), 73.11 (C-4), 76.07 (C-1), 118.96, 122.78, 128.11, 130.90 (Ar), 134.05 (ArC-S), 143.18 (C=N) ppm. <sup>13</sup>C-NMR spectrum (DMSOd<sub>6</sub>): δ = form A(40%): 63.91 (C-5), 70.87 (C-2), 71.22 (C-3), 72.29 (C-4), 131.81 (ArC-S), 144.50 (C-1), 183.48 (C=S); form C(60%): 63.62 (C-5), 69.90 (C-2), 71.08 (C-3), 72.73 (C-4), 75.91 (C-1), 131.54 (ArC-S), 142.69 (C=N), 121.27 - 131.41 (Ar in A and C) ppm. Found, %: C 50.73; H 5.61; N 9.79. C<sub>12</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>S. Calculated, %: C 50.69; H 5.67; N 9.85.</p><p>L-Arabinose 2-sulfanylacetylhydrazone (2a)</p><p>Yield 75%, m.p. 120 <sup>&#176;</sup>C - 121 <sup>&#176;</sup>C . <sup>13</sup>C-NMR spectrum (D<sub>2</sub>O): δ = α-B(10%): 25.52 (CH<sub>2</sub>SH), 62.38 (C-5), 67.31 (C-4), 68.09 (C-2), 72.71 (C-3), 90.40 (C-1), 172.36 (C=O); form D(55%): 26.90 (CH<sub>2</sub>S), 63.02 (C-5), 65.58 (C-1), 69.60 (C-2), 70.57 (C-3), 71.12 (C-4), 177.19 (C=O); form D′(35%): 27.04 (CH<sub>2</sub>S), 62.88 (C-5), 64.40 (C-1), 69.72 (C-2), 70.04 (C-3), 70.87 (C-4), 176.63 (C=O) ppm. Found, %: C 35.34; H 5.88; N 11.80. C<sub>7</sub>H<sub>14</sub>N<sub>2</sub>O<sub>5</sub>S. Calculated, %: C 35.29; H 5.92; N 11.76.</p><p>L-Arabinose 3-sulfanylpropionylhydrazone (3a)</p><p>Yield 55%, m.p. 146˚C - 148˚C. <sup>13</sup>C-NMR spectrum (solid phase): δ = forms E, E′(100%): 23.74 and 30.14 (CH<sub>2</sub>S), 35.95 and 39.48 (CH<sub>2</sub>CO), 63.23 and 64.70 (C-5), 69.78 (C-2), 70.79 (C-3), 71.17 (C-4), 77.34 (C-1), 170.81 (C=O) ppm. <sup>13</sup>C-NMR spectrum (D<sub>2</sub>O): δ = form A(5%): 152.03 (C-1), 169.78 (C=O); forms E, E′(30%): 24.48 and 25.04 (CH<sub>2</sub>S), 33.41 and 34.16 (CH<sub>2</sub>CO), 63.70 (C-5), 67.48 (C-1), 69.57 (C-4), 70.23 (C-3), 70.49 (C-2), 172.11 (C=O); α-B(10%): 19.32 (CH<sub>2</sub>SH), 36.77 (CH<sub>2</sub>CO), 61.82 (C-5), 68.24 (C-2), 69.07 (C-3), 70.03 (C-4), 85.98 (C-1), 172.63 (C=O); β-B(55%): 19.34 (CH<sub>2</sub>S), 37.05 (CH<sub>2</sub>CO), 62.46 (C-5), 68.83 (C-4), 70.29 (C-2), 72.04 (C-3), 89.83 (C-1), 172.57 (C=O) ppm. Found, %: C 38.03; H 6.44; N 11.06. C<sub>8</sub>H<sub>16</sub>N<sub>2</sub>O<sub>5</sub>S. Calculated, %: C 38.09; H 6.39; N 11.10.</p><p>L-Arabinose 2-sulfanylbenzoylhydrazone (4a)</p><p>Yield 60%, m.p. 177˚C - 178˚C (lit. [<xref ref-type="bibr" rid="scirp.69302-ref4">4</xref>] m.p. 175˚C - 176˚C). <sup>1</sup>H-NMR spectrum (DMSOd<sub>6</sub>): δ = form F(75%): 9.24 (br.s, NHCO); form F′(25%): 9.24 (br.s, NHCO) ppm. <sup>13</sup>C-NMR spectrum (DMSOd<sub>6</sub>): δ = form F: 63.37 (C-5), 69.40 (C-2), 70.08 (C-3), 71.51 (C-4), 75.40 (C-1), 140.13 (ArC-S), 175.40 (C=O); form F′: 63.61 (C-5), 69.40 (C-2), 70.38 (C-3), 71.01 (C-4), 74.24 (C-1), 140.13 (ArC-S), 172.75 (C=O), 127.90 - 133.47 (Ar in F and F′) ppm. Found, %: C 48.06; H 5.29; N 9.41. C<sub>12</sub>H<sub>16</sub>N<sub>2</sub>O<sub>5</sub>S. Calculated, %: C 47.99; H 5.37; N 9.33.</p><p>Spectral characteristics of compounds 1b-1e, 2b-2f, 3b-2f, and 4b-4f were described previously [<xref ref-type="bibr" rid="scirp.69302-ref9">9</xref>] - [<xref ref-type="bibr" rid="scirp.69302-ref12">12</xref>] .</p></sec><sec id="s5"><title>Acknowledgements</title><p>This work received financial support from the Ministry of Education and Science of Russian Federation (contract 14.574.21.0002, No. RFMEFI57414X0002).</p></sec><sec id="s6"><title>Cite this paper</title><p>Andrei Yu Ershov,Igor V. Lagoda,Stanislav I. Yakimovich,Lyudmila Yu Kuleshova,Marina Yu Vasileva,Irina S. Korovina,Valery V. Shamanin, (2016) Structure of Aldoses Condensation Products with SH-Containing Hydrazides. Open Access Library Journal,03,1-6. doi: 10.4236/oalib.1102646</p></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.69302-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Katz, L. (1956) Bactericidal and Fungicidal Compounds. US Patent No. 2767173.</mixed-citation></ref><ref id="scirp.69302-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Kuleshova, L.Y., Frolova, M.A., Konopleva, V.I., Alekseev, V.V. and Ershov, A.Y. (2012) 2-Mercaptobenzoyl Hydrazones of Monose, Having Antimicrobial and Antifungal Activity. RF Patent No. 2454423.</mixed-citation></ref><ref id="scirp.69302-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holmberg</surname><given-names> B. </given-names></name>,<etal>et al</etal>. (<year>1955</year>)<article-title>Zur kenntnis des thiobenzhydrazinen</article-title><source> Arkiv f&amp;#246;r Kemi</source><volume> 9</volume>,<fpage> 47</fpage>-<lpage>64</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.69302-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Katz, L., Karger, L.S., Schroeder, W. and Cohen, M.S. (1953) Hydrazine Derivatives. I. Benzalthio- and Bisbenzaldi-Thiosalicylhydrazides. Journal of Organic Chemistry, 18, 1380-1402. http://dx.doi.org/10.1021/jo50016a019</mixed-citation></ref><ref id="scirp.69302-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Ershov, A.Y., Lagoda, I.V., Yakimovich, S.I., Pakalnis, V.V., Zerova, I.V., Dobrodumov, A.V. and Shamanin, V.V. (2009) Tautomerism and Conformational Isomerism of Mercaptoacetylhydrazones of Aliphatic and Aromatic Aldehydes. Russian Journal of Organic Chemistry, 45, 660-666. http://dx.doi.org/10.1134/S1070428009050030</mixed-citation></ref><ref id="scirp.69302-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Ershov, A.Y., Lagoda, I.V., Mokeev, M.V., Yakimovich, S.I., Zerova, I.V., Pakalnis, V.V. and Shamanin, V.V. (2008) Thiosalicyloylhydrazones of Alyphatic Aldehydes and Their Cyclization into 1,3,4-Benzothiadiazepine Derivatives. Chemistry of Heterocyclic Compounds, 44, 356-359. http://dx.doi.org/10.1007/s10593-008-0052-2</mixed-citation></ref><ref id="scirp.69302-ref7"><label>7</label><mixed-citation publication-type="book" xlink:type="simple">Garc&amp;#237;a, I., Gallo, J., Marradi, M. and Penadés, S. (2011) Glyconanoparticles: New Nanomaterials for Biological Application. In: Narain, R., Ed., Engineered Carbohydrate-Based Materials for Biomedical Applications: Polymers, Surfaces, Dendrimers, Nanoparticles, and Hydrogels, John Wiley &amp; Sons, Inc., Hoboken, 213-259.http://dx.doi.org/10.1002/9780470944349</mixed-citation></ref><ref id="scirp.69302-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Chuang, Y.-J., Zhou, X., Pan, Z. and Turchi, C. (2009) A Convenient Method for Synthesis of Glyconanoparticles for Colorimetric Measuring Carbohydrate-Protein Interactions. Biochemical and Biophysical Research Communications, 389, 22-27. http://dx.doi.org/10.1016/j.bbrc.2009.08.079</mixed-citation></ref><ref id="scirp.69302-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Zelenin, K.N., Alekseev, V.V., Kuznetsova, O.B., Terentev, P.B., Lashin, V.V., Ovcharenko, V.V. and Khorseeva, L.A. (1993) Thiosemicarbazones, Thiobenzoylhydrazones and Thiocarbonohydrazones of Monoses. Russian Journal of Organic Chemistry, 29, 278-286.</mixed-citation></ref><ref id="scirp.69302-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ershov, A.Y., Lagoda, I.V., Yakimovich, S.I., Zerova, I.V., Pakalnis, V.V., Mokeev, M.V. and Shamanin, V.V. (2009) Structure of Products of Aldoses Condensation with Thioglycolic Acid Hydrazide. Russian Journal of Organic Chemistry, 45, 740-742. http://dx.doi.org/10.1134/S1070428009050169</mixed-citation></ref><ref id="scirp.69302-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ershov, A.Y., Lagoda, I.V., Yakimovich, S.I., Zerova, I.V., Pakalnis, V.V. and Shamanin, V.V. (2009) Structure of the Condensation Products of 3-Sulfanylpropionic Acid Hydrazide with Aldehydes, Ketones, and Aldoses. Russian Journal of Organic Chemistry, 45, 1488-1495. http://dx.doi.org/10.1134/S107042800910011X</mixed-citation></ref><ref id="scirp.69302-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Alekseev, V.V., Ershov, A.Y., Chernitsa, B.V., Doroshenko, V.A., Lagoda, I.V., Yakimovich, S.I., Zerova, I.V., Pakalnis, V.V. and Shamanin, V.V. (2010) Structure of Aldoses Condensation Products with 2-Hydroxy- and 2-Sulfanyl-Benzohydrazides. Russian Journal of Organic Chemistry, 46, 860-865. http://dx.doi.org/10.1134/S1070428010060138</mixed-citation></ref></ref-list></back></article>